Vanguard and BlackRock split in a close vote on CEO pay at drug distributor AmerisourceBergen

Vanguard and BlackRock split in a close vote on CEO pay at drug distributor AmerisourceBergen

Source: 
Philadelphia Inquirer, PA
snippet: 

Ever since Steve Collis became CEO of drug distributor AmerisourceBergen in 2011, shareholders had voted overwhelmingly in favor of how much he got paid.

That changed last week, after a group of investors challenged Collis’ $14.3 million compensation, and 26% raise, given him despite the billions the distributor is preparing to pay to settle nationwide opioid lawsuits.